India has made a significant advancement in cancer treatment with the introduction of CAR T-cell therapy, showing promising results in recent clinical trials published in The Lancet. Here's a simplified explanation: What is CAR T-cell therapy? A new type of cancer treatment that uses the patient's own immune system. T-cells (a type of white blood cell) are collected from the patient's blood. In a lab, these T-cells are genetically modified to attack cancer cells. The modified T-cells are then infused back into the patient. What types of cancer does it treat? Certain blood cancers, especially when other treatments have failed. What were the results of the clinical trials? Nearly 73% of patients responded positively to the treatment. The trials also provided important data on survival rates for patients with acute lymphoblastic leukemia and lymphoma. Is it available in India? Yes, India's drug regulator approved the ...